Logo | Name | Σ | ||
---|---|---|---|---|
UL Solutions A global leader in applied safety science, UL Solutions (NYSE: ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers’ product innovation and business growth. The UL Mark serves as a recognized symbol of trust in our customers’ products and reflects an unwavering commitment to advancing our safety mission. We help our customers innovate, launch new products and services, navigate global markets and complex supply chains, and grow sustainably and responsibly into the future. Our … Sectors: Real Estate | 757 | 392 | 63 | |
Illumina For Startups Illumina for Startups supporting genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include Startups Grants for founders to work with Illumina sites to run proof-of-concept sequencing experiments. For more information visit https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK. Illumina Accelerator … Sectors: Biotechnology Startup accelerator & VC | 917 | 456 | 155 | |
Cambridge Science Park Building a better world for everyone. Since it was established by Trinity College in 1970, the Cambridge Science Park has played a pivotal role in the “Cambridge Phenomenon” - the transformation of Cambridge from a market town with a world-class university to one of the hottest technology hotspots in the world. Today the 152-acre site is home to 100 science and technology companies ranging from spin-outs from the University of Cambridge to multinational companies seeking access to the brightest graduates and entrepreneurs from Cambridge’s diverse talent pool. Many are working on potentially life changing technologies from personalised medicines and non-invasive … Sectors: Real Estate Startup accelerator & VC | 172 | 85 | 41 | |
AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3790 | 2621 | 203 | |
UK Research and Innovation Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves … Sectors: Public business cluster | 4041 | 2861 | 695 | |
Teva Pharmaceuticals Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please … Sectors: Pharmaceutical | 1860 | 1017 | 248 |